Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1974 Apr;27(4):269–272. doi: 10.1136/jcp.27.4.269

The effect of minocycline on Candida albicans

Pamela M Waterworth 1
PMCID: PMC478100  PMID: 4212409

Abstract

Minocycline, a new tetracycline derivative, was found to inhibit the growth of Candida albicans. Inhibition was much affected by the composition of the medium and was difficult to demonstrate in fluid cultures. Study of the rate of budding in shallow broth cultures in Petri dishes showed that the addition of 20 μg/ml minocycline prolonged the lag phase by three hours. C. tropicalis was similarly inhibited and C. guilliermondii and C. parapsilosis to a lesser degree. Six other tetracyclines were tested and found to inhibit Candida only in very high concentrations.

Full text

PDF
269

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Martell M. J., Jr, Boothe J. H. The 6-deoxytetracyclines. VII. Alkylated aminotetracyclines possessing unique antibacterial activity. J Med Chem. 1967 Jan;10(1):44–46. doi: 10.1021/jm00313a009. [DOI] [PubMed] [Google Scholar]
  2. Nicholls M. W. Polymyxin sensitivity of Candida tropicalis. J Med Microbiol. 1970 Aug;3(3):529–538. doi: 10.1099/00222615-3-3-529. [DOI] [PubMed] [Google Scholar]
  3. Steigbigel N. H., Reed C. W., Finland M. Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro. Am J Med Sci. 1968 Mar;255:179–195. doi: 10.1097/00000441-196803000-00005. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES